One institutional experience with imatinib mesylate in the treatment of gastrointestinal stromal tumors

被引：0
|
作者：
Tamas, Karin R.
Papai, Zsuzsa
Vegh, Eva A.
Petranyi, Agota E.
Szucs, Zoltan
Rohanszky, Magda
Aranyi, Zsuzsa
Bodoky, Gyorgy
机构：
[1] St Laslo Hosp, Budapest, Hungary
[2] Natl Med Ctr, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [41] Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: A report of two cases
    Hasan, S
    Hassan, M
    Oke, L
    Dinh, K
    Onojobi, G
    Lombardo, F
    Dawkins, F
    Jack, M
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (12) : 1208 - 1210
  • [42] Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case
    Ando, Koji
    Oki, Eiji
    Sugiyama, Masahiko
    Zhao, Yan
    Kojima, Aya
    Yamamoto, Hidetaka
    Yamashita, Yoichi
    Saeki, Hiroshi
    Taketomi, Akinobu
    Morita, Masaru
    Kakeji, Yoshihiro
    Tsujitani, Shunichi
    Maehara, Yoshihiko
    SURGERY TODAY, 2011, 41 (09) : 1290 - 1293
  • [43] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
    Tonyali, Onder
    Coskun, Ugur
    Yildiz, Ramazan
    Karakan, Tarkan
    Demirci, Umut
    Akyurek, Nalan
    Benekli, Mustafa
    Buyukberber, Suleyman
    MEDICAL ONCOLOGY, 2010, 27 (03) : 768 - 773
  • [44] Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
    Fiore, M.
    Palassini, E.
    Fumagalli, E.
    Pilotti, S.
    Tamborini, E.
    Stacchiotti, S.
    Pennacchioli, E.
    Casali, P. G.
    Gronchi, A.
    EJSO, 2009, 35 (07): : 739 - 745
  • [45] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
    Onder Tonyali
    Ugur Coskun
    Ramazan Yildiz
    Tarkan Karakan
    Umut Demirci
    Nalan Akyurek
    Mustafa Benekli
    Suleyman Buyukberber
    Medical Oncology, 2010, 27 : 768 - 773
  • [46] Gastrointestinal stromal tumors: Overview of pathologic features, molecular biology, and therapy with imatinib mesylate
    Koh, JS
    Trent, J
    Chen, L
    El-Naggar, A
    Hunt, K
    Pollock, R
    Zhang, W
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (02) : 565 - 574
  • [47] Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors
    Casali, PG
    Bertulli, R
    Fumagalli, E
    Coco, P
    Grosso, F
    Stacchiotti, S
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 55 - 58
  • [48] Imatinib mesylate activates IGFBP3 expression in gastrointestinal stromal tumors.
    Dupart, J
    Trent, JC
    Cohen, P
    Zhang, W
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8987S
  • [49] Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate
    Jacopo Giuliani
    Andrea Bonetti
    Chinese Journal of Cancer Research, 2013, 25 (05) : 486 - 487
  • [50] Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case
    Koji Ando
    Eiji Oki
    Masahiko Sugiyama
    Yan Zhao
    Aya Kojima
    Hidetaka Yamamoto
    Yoichi Yamashita
    Hiroshi Saeki
    Akinobu Taketomi
    Masaru Morita
    Yoshihiro Kakeji
    Shunichi Tsujitani
    Yoshihiko Maehara
    Surgery Today, 2011, 41 : 1290 - 1293
12345